Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Go back to Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
(NASDAQ: XENE) Delayed: 59.94 -1.02 (1.67%)
Previous Close $60.96    52 Week High $9.75 
Open $60.78    52 Week Low $5.65 
Day High $61.17    P/E N/A 
Day Low $59.82    EPS $0.00 
Volume 273,198